Skip to search formSkip to main contentSkip to account menu

UK 38,485

Known as: UK 38485, UK-38,485 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dazmegrel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud’s syndrome
SummaryTen patients with moderate to severe Raynaud’s syndrome were recruited into a four week randomised double blind crossover… 
1991
1991
Prostacyclin and prostanoid modifiers aid ischemic skin flap survival.
Highly Cited
1991
Highly Cited
1991
Thromboxane mediates renal hemodynamic response to infused angiotensin II.
UNLABELLED Since we had found that angiotensin II (Ang II), but not phenylephrine (PE), increased the excretion of thromboxane… 
1990
1990
The Effect of Thromboxane Synthetase Inhibition on Tolerance of Skin Flaps to Secondary Ischemia Caused by Venous Obstruction
The harmful effects of the no-reflow phenomenon on skin flaps were modified by using the thromboxane synthetase inhibitor UK-38… 
1990
1990
Effect of a thromboxane synthetase inhibitor UK-38,485 on the tolerance of skin flaps of primary ischaemia.
The harmful effects of ischaemia or skin flaps were modified using the thromboxane synthetase inhibitor UK-38,485. The epigastric… 
1986
1986
The effect of predetermined thrombotic potential of the recipient on small-caliber graft performance.
1986
1986
Response of the rabbit cutaneous microcirculation to prostanoid modifiers as determined by laser Doppler flowmetry.
1985
1985
Opposing hemodynamic effects of substance P on pulmonary vasculature in rabbits.
Substance P is a peptide implicated in the control of a variety of physiological processes. Although substance P-containing… 
Highly Cited
1984
Highly Cited
1984
SPECIFIC THROMBOXANE SYNTHETASE INHIBITION AND ALBUMIN EXCRETION RATE IN INSULIN-DEPENDENT DIABETES
Highly Cited
1983
Highly Cited
1983
The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
UK-38,485, a novel imidazole derivative, was used in two clinical trials with healthy male subjects to study the influence of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)